EPISIL monthly revenue
EPISIL
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$0.6B | +5.1% | +29.9% | NT$3.3B |
| May 2026 | Jun 17, 2026 | NT$0.6B | +1.0% | +28.0% | NT$2.7B |
| Apr 2026 | May 17, 2026 | NT$0.6B | +7.7% | +31.0% | NT$2.1B |
| Mar 2026 | Apr 17, 2026 | NT$0.5B | +11.2% | +22.3% | NT$1.5B |
| Feb 2026 | Mar 17, 2026 | NT$0.5B | -3.1% | +13.4% | NT$1B |
| Jan 2026 | — | NT$0.5B | — | +25.0% | NT$0.5B |
| Dec 2025 | — | NT$0.5B | — | +14.8% | NT$5.8B |
| Nov 2025 | — | NT$0.5B | — | +10.8% | NT$5.3B |
| Oct 2025 | — | NT$0.5B | — | +11.2% | NT$4.7B |
| Sep 2025 | — | NT$0.5B | — | +10.6% | NT$4.2B |
| Aug 2025 | — | NT$0.5B | — | +0.3% | NT$3.7B |
| Jul 2025 | — | NT$0.5B | — | +0.7% | NT$3.2B |
| Jun 2025 | — | NT$0.5B | — | -2.6% | NT$2.7B |
| May 2025 | — | NT$0.5B | — | -6.2% | NT$2.2B |
| Apr 2025 | — | NT$0.4B | — | -10.7% | NT$1.7B |
| Mar 2025 | — | NT$0.4B | — | -8.3% | NT$1.3B |
| Feb 2025 | — | NT$0.4B | — | -6.2% | NT$0.8B |
| Jan 2025 | — | NT$0.4B | — | -21.7% | NT$0.4B |
| Dec 2024 | — | NT$0.4B | — | -20.4% | NT$5.8B |
| Nov 2024 | — | NT$0.5B | — | -10.4% | NT$5.4B |
| Oct 2024 | — | NT$0.5B | — | -8.7% | NT$4.9B |
| Sep 2024 | — | NT$0.5B | — | -12.5% | NT$4.4B |
| Aug 2024 | — | NT$0.5B | — | -15.4% | NT$3.9B |
| Jul 2024 | — | NT$0.5B | — | -22.4% | NT$3.4B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-07-29. Source: Company websiteTaiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.